Brief: Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing
11/06/2026 13:02
BRIEF-Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing June 11 (Reuters) - Summit Therapeutics Inc SMMT.O:
SUMMIT THERAPEUTICS - WITHDRAWS PROPOSED UNDERWRITTEN PUBLIC OFFERING EFFECTIVE JUNE 10, 2026 - SEC FILING
SUMMIT THERAPEUTICS - NO SECURITIES TO BE SOLD IN PROPOSED UNDERWRITTEN PUBLIC OFFERING - SEC FILING
Source text: [ID:n0001599298-26-000052]
Further company coverage: SMMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Summit Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
Summit Therapeutics rebounds after pulling stock offering
Brief: Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing
Summit Therapeutics falls on launching $500 mln stock offering